Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 051
mi
from
Brooklyn, NY
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 051
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 037
mi
from
Mount Kisco, NY
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 037
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 025
mi
from
New York, NY
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 025
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 025
mi
from
New York, NY
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 025
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 036
mi
from
Canton, OH
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 036
mi
from
Canton, OH
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative site 026
mi
from
Dayton, OH
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative site 026
mi
from
Dayton, OH
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site
mi
from
Portland, OR
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 058
mi
from
Salem, OR
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 058
mi
from
Salem, OR
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site #008
mi
from
Bridgeville, PA
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site #008
mi
from
Bridgeville, PA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 019
mi
from
Philadelphia, PA
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 019
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 110
mi
from
Reading, PA
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 110
mi
from
Reading, PA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site
mi
from
Memphis, TN
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 014
mi
from
Austin, TX
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 014
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 014
mi
from
Austin, TX
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 014
mi
from
Austin, TX
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site
mi
from
Dallas, TX
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site
mi
from
Houston, TX
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 062
mi
from
San Antonio, TX
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 062
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative site 100
mi
from
Salt Lake City, UT
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative site 100
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site
mi
from
Bellevue, WA
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 034
mi
from
Kirkland, WA
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 034
mi
from
Kirkland, WA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 064
mi
from
Gainesville, FL
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 064
mi
from
Gainesville, FL
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 066
mi
from
Smyrna, GA
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 066
mi
from
Smyrna, GA
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 088
mi
from
Marlton, NJ
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 088
mi
from
Marlton, NJ
Click here to add this to my saved trials
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated:  3/29/2018
Forest Investigative Site 203
mi
from
Tallinn,
Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
A Double-Blind, Placebo-Controlled Study of Cariprazine (RGH-188) as Adjunctive Therapy in Major Depressive Disorder
Status: Enrolling
Updated: 3/29/2018
Forest Investigative Site 203
mi
from
Tallinn,
Click here to add this to my saved trials
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression: A Raclopride/F-DOPA Positron Emission Tomography and Functional MRI Study
Status: Enrolling
Updated:  4/17/2018
Washington University in St. Louis School of Medicine
mi
from
Saint Louis, MO
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression: A Raclopride/F-DOPA Positron Emission Tomography and Functional MRI Study
Status: Enrolling
Updated: 4/17/2018
Washington University in St. Louis School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
The Role Of Omega-3 Fatty Acids In Adolescent Depression
The Role Of Omega-3 Fatty Acids In Adolescent Depression
Status: Enrolling
Updated:  4/20/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
The Role Of Omega-3 Fatty Acids In Adolescent Depression
The Role Of Omega-3 Fatty Acids In Adolescent Depression
Status: Enrolling
Updated: 4/20/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials
The Effects of Dopamine on Reward Processing
The Effects of Dopamine on Reward Processing
Status: Enrolling
Updated:  4/25/2018
McLean Hospital
mi
from
Belmont, MA
The Effects of Dopamine on Reward Processing
The Effects of Dopamine on Reward Processing
Status: Enrolling
Updated: 4/25/2018
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Exploring Biomarkers for Depression
Exploring Biomarkers for Depression
Status: Enrolling
Updated:  4/30/2018
Depression Clinical and Research Program, MGH
mi
from
Boston, MA
Exploring Biomarkers for Depression
Exploring Biomarkers for Depression
Status: Enrolling
Updated: 4/30/2018
Depression Clinical and Research Program, MGH
mi
from
Boston, MA
Click here to add this to my saved trials